Evidence map›Paper›PMID 38150055›Full record

ArticleClinical rheumatology2024

Characteristics of patients with initial diagnosis of systemic lupus erythematosus in emergency department and their outcomes: a retrospective single-center study.

Xiaoying Zhang, Xiaojing Song, Su Lv, Jia Li, Yuebo Jin, Jiayang Jin, Miao Shao, Jihong Zhu, Cheng Chi

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xiaoying ZhangDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Xiaojing SongDepartment of Emergency, Peking University People's Hospital, 11 Xizhimen South St, Beijing, 100044, China.
Su LvDepartment of Emergency, Peking University People's Hospital, 11 Xizhimen South St, Beijing, 100044, China.
Jia LiDepartment of Emergency, Peking University People's Hospital, 11 Xizhimen South St, Beijing, 100044, China.
Yuebo JinDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Jiayang JinDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Miao ShaoDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Jihong ZhuDepartment of Emergency, Peking University People's Hospital, 11 Xizhimen South St, Beijing, 100044, China.
Cheng ChiDepartment of Emergency, Peking University People's Hospital, 11 Xizhimen South St, Beijing, 100044, China. chichengpku@bjmu.edu.cn.ORCID http://orcid.org/0000-0002-1146-966X
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectiveThis study aims to investigate the characteristics of patients with an initial diagnosis of systemic lupus erythematosus (SLE) in an emergency department (ED) and their outcomes.

methodsA total of 147 SLE patients (119 females and 28 males, mean age 26 ± 19 years) who visited the ED of the Peking University People's Hospital between January 2017 and June 2022 were enrolled in the study. Data on demographic information, clinical characteristics, comorbidities, therapy, and outcomes were collected.

resultsMost patients visit ED because of symptoms related to SLE (74.8%, 110/147). The remaining 37 patients (25.2%) visited ED due to infection (43.2%, 16/37), gastrointestinal bleeding (10.8%, 4/37), coronary heart or cerebrovascular disease (18.9%, 7/37), macrophage activation syndrome or thrombotic microangiopathy (18.9%, 7/37), leukemia (5.4%, 2/37), and hepatic encephalopathy (2.7%, 1/37). Of the patients, 54.4% (80/147) were first diagnosed with SLE at the time of their ED visit. Thrombocytopenia events occurred significantly more frequently in this group of patients (OR 3.664, 95% CI 1.586-8.464, p = 0.002). Pulse steroid therapy was administered to 32.5% (26/80) of the patients with an initial diagnosis of SLE, and 26.3% (21/80) of these patients also received IVIG therapy during their ED visit. SLEDAI scores were significantly decreased after 6 months of therapy. The rate of mortality was 6.8% (10/147) in the 6-month follow-up period, and all the ten deaths happened in patients with disease-established SLE. The main causes of death were infections (two patients) and SLE flare (four patients).

conclusionUnderstanding disease patterns can contribute to physicians providing accurate diagnosis and efficient care for SLE patients in ED. Key Points • Systemic lupus erythematosus, a complex autoimmune disorder, can have either a chronic or a relapsing and remitting disease course. The disease can involve acute events or severe comorbidities, and frequent visits to the emergency department (ED) are inevitable. • It is essential to better understand which comorbidities can lead to emergency department visits. Accurate clinical diagnosis and appropriate interventions from ED physicians can have a strong impact on the prognosis of the disease. • Hematologic compromise attributed to SLE flare is the most common reason for ED visits. Owing to aggressive treatments, the clinical outcomes in patients with initial diagnosis of SLE have improved notably. • Our study highlights that early recognition and appropriate management of SLE-related conditions and other comorbidity in ED are crucial.

Indexed as

Lupus Erythematosus, SystemicAdolescentAdultChildDisease ProgressionEmergency Service, HospitalFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesYoung AdultEmergency departmentInitial diagnosisSystemic lupus erythematosus

Identifiers

PMID38150055
OpenAlexW4390272272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.